Share-based Payment Arrangement, Expense of HAEMONETICS CORP from 03 Apr 2010 to 27 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
HAEMONETICS CORP quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 03 Apr 2010 to 27 Sep 2025.
  • HAEMONETICS CORP Share-based Payment Arrangement, Expense for the quarter ending 27 Sep 2025 was $7,589,000, a 11% increase year-over-year.
  • HAEMONETICS CORP annual Share-based Payment Arrangement, Expense for 2024 was $29,636,000, a 4.6% increase from 2023.
  • HAEMONETICS CORP annual Share-based Payment Arrangement, Expense for 2023 was $28,332,000, a 11% increase from 2022.
  • HAEMONETICS CORP annual Share-based Payment Arrangement, Expense for 2022 was $25,583,000, a 5% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

HAEMONETICS CORP Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,589,000 +$732,000 +11% 29 Jun 2025 27 Sep 2025 10-Q 06 Nov 2025 2026 Q2
Q2 2025 $9,312,000 +$1,684,000 +22% 30 Mar 2025 28 Jun 2025 10-Q 07 Aug 2025 2026 Q1
Q3 2024 $6,857,000 30 Jun 2024 28 Sep 2024 10-Q 06 Nov 2025 2026 Q2
Q2 2024 $7,628,000 31 Mar 2024 29 Jun 2024 10-Q 07 Aug 2025 2026 Q1
Q2 2015 $3,164,000 -$325,000 -9.3% 29 Mar 2015 27 Jun 2015 10-Q 30 Jul 2015 2016 Q1
Q2 2014 $3,489,000 +$489,000 +16% 30 Mar 2014 28 Jun 2014 10-Q 30 Jul 2015 2016 Q1
Q2 2013 $3,000,000 +$600,000 +25% 31 Mar 2013 29 Jun 2013 10-Q 31 Jul 2014 2015 Q1
Q2 2012 $2,400,000 $0 0% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2012 2012 Q1
Q2 2011 $2,400,000 +$200,000 +9.1% 03 Apr 2011 02 Jul 2011 10-Q 10 Aug 2011 2011 Q1
Q2 2010 $2,200,000 04 Apr 2010 03 Jul 2010 10-Q 10 Aug 2011 2011 Q1

HAEMONETICS CORP Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $29,636,000 +$1,304,000 +4.6% 31 Mar 2024 29 Mar 2025 10-K 21 May 2025 2025 FY
2023 $28,332,000 +$2,749,000 +11% 02 Apr 2023 30 Mar 2024 10-K 21 May 2025 2025 FY
2022 $25,583,000 +$1,224,000 +5% 03 Apr 2022 01 Apr 2023 10-K 21 May 2025 2025 FY
2021 $24,359,000 -$1,157,000 -4.5% 04 Apr 2021 02 Apr 2022 10-K 20 May 2024 2024 FY
2020 $25,516,000 +$5,062,000 +25% 29 Mar 2020 03 Apr 2021 10-K 22 May 2023 2023 FY
2019 $20,454,000 +$3,266,000 +19% 31 Mar 2019 28 Mar 2020 10-K 25 May 2022 2022 FY
2018 $17,188,000 +$4,163,000 +32% 01 Apr 2018 30 Mar 2019 10-K 26 May 2021 2021 FY
2017 $13,025,000 +$3,875,000 +42% 02 Apr 2017 31 Mar 2018 10-K 20 May 2020 2020 FY
2016 $9,150,000 +$2,201,000 +32% 03 Apr 2016 01 Apr 2017 10-K 22 May 2019 2019 FY
2015 $6,949,000 -$7,146,000 -51% 29 Mar 2015 02 Apr 2016 10-K 23 May 2018 2018 FY
2014 $14,095,000 +$1,013,000 +7.7% 30 Mar 2014 28 Mar 2015 10-K 24 May 2017 2017 FY
2013 $13,082,000 +$2,082,000 +19% 31 Mar 2013 29 Mar 2014 10-K 01 Jun 2016 2016 FY
2012 $11,000,000 +$1,700,000 +18% 01 Apr 2012 30 Mar 2013 10-K 22 May 2015 2015 FY
2011 $9,300,000 -$1,500,000 -14% 03 Apr 2011 31 Mar 2012 10-K 22 May 2014 2013 FY
2010 $10,800,000 +$500,000 +4.9% 04 Apr 2010 02 Apr 2011 10-K 20 May 2013 2012 FY
2009 $10,300,000 29 Mar 2009 03 Apr 2010 10-K 22 May 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.